Extending our previous findings, we report based on the results from the present study that i) Prenatal stress increases stress axis activity as marked by increases in NE levels in the PVN and CRH levels in the median eminence both in DR and DIO animals, irrespective of postnatal HF diet treatment ii) This central hyperactivation of stress axis was not accompanied by increases in circulating CORT levels or adrenal gland weight iii) Prenatal stress resulted in up regulation of 11βHSD1 specifically in the adipose tissue but not in the liver suggesting that prenatal stress induces tissue specific programming of 11βHSD1 expression both in DR and DIO animals.
Our results are in agreement with other studies examining the effects of prenatal stress on stress axis function in terms of NE and CRH concentrations in the offspring. Prenatal stress has been reported to increase NE concentrations in the hypothalamus26 and increase NE turnover rate in the brain stem suggesting higher NE release27. Also, CRH concentrations in the amygdala, which is another stress regulating center in the brain, was increased in the prenatally stressed offspring28. Apart from being a part of stress axis, PVN also regulates feeding behavior. Acute and chronic infusion of NE in the PVN produces hyperphagia and promotes obesity29,30. Hence, the increase in PVN NE concentrations observed in the prenatally stressed offspring might lead to hyperphagia in the offspring’s adulthood.
In the current study, despite increases in NE and CRH levels, we did not observe any changes in baseline CORT levels between stressed and non-stressed DIO and DR offspring. Previously, studies have demonstrated a similar finding where there was no difference in baseline CORT levels in prenatally stressed offspring at postnatal day (PND) 21 2,31 and PND9031. On the other hand, few other studies have also showed an increase in baseline CORT in the offspring subjected to prenatal stress32 and prolonged CORT response to stress33. The disparity in the findings might be due to the differences in the stress protocol and the age at which CORT measurements were made in the offspring. Further, based on the results from the present study, it is still not clear whether increased renal clearance have masked the true CORT levels in the prenatally stressed DIO/DR offspring. Additional studies on CORT metabolite measurements in the urine are needed to answer this question.
Despite no detectable changes in circulating CORT levels, glucocorticoids might still play a role in the peripheral metabolic outcomes observed in the prenatally stressed DIO offspring through the enzyme, 11βHSD1. 11βHSD1 is involved in pre-receptor metabolism of CORT in the metabolically active peripheral tissues like liver and the adipose tissue where it converts inactive 11-dehydroCORT to active CORT8,9. Irrespective of circulating CORT levels, increase in 11βHSD1 expression in these tissues will result in amplification of glucocorticoid actions leading to obesity and insulin resistance8. In the present study, prenatal stress mediated increase in 11βHSD1 protein expression was tissue specific as we observed it specifically in the adipose tissue but not in the liver. Supporting tissue-specific programming of 11βHSD1 expression, studies have shown that dexamethasone treatment during late gestation and diabetic pregnancy results in offspring with higher 11βHSD1 expression in the liver and adipose tissue20,21. Similarly, postnatal overfeeding, also known to program the offspring for obesity, results in higher 11βHSD1 expression in the adipose tissue34. Interestingly, prenatal stress also resulted in increased 11βHSD1 protein expression in the DR offspring, which did not have any adverse metabolic outcomes and stress axis hyperactivation as observed in DIO animals. Whether this has any physiological significance in the DR animals will remain a question until further experiments on chronic HF diet exposure are carried out. Also, prenatally stressed offspring with elevated 11βHSD1 expression in the adipose tissue are not overtly obese when compared with their non-stressed counterparts. In concordance with our results, maternal perinatal undernutrition and dexamethasone administration during late gestation also resulted in the offspring with a lean phenotype but with a lipogenic adipose tissue gene profile20,35. Taken together, these studies suggest that elevated 11βHSD1 expression precedes obesity in by fetal programming.
There are several mechanisms by which increased 11βHSD1 and its resultant increase in intra-adipocyte CORT could contribute to the development of obesity and metabolic syndrome. In the adipose tissue, glucocorticoids regulate the activity and expression of lipoprotein lipase (LPL)36, an enzyme expressed in the endothelial cells that catalyzes the conversion of circulating triglycerides to FFA which is then re-esterified to be stored in the adipocytes37. Higher LPL activity results in more triglyceride accumulation and hypertrophy of the adipocytes leading to an unhealthy pro-inflammatory and insulin resistant adipose tissue. This condition is further compounded by the anti-lipolytic actions of insulin during the hyper insulinemic state38. Glucocorticoids also promote pre-adipocyte differentiation and proliferation resulting in increase in fat mass. In addition to lipogenesis, glucocorticoids can also cause lipolysis by stimulating hormone sensitive lipase in the adipose tissue which increases FFA flux into the portal circulation and thus facilitates ectopic fat distribution in liver and muscle39.
In summary, the present study suggests that prenatal stress results in hyperactivation of stress axis with simultaneous up regulation of 11βHSD1 in the visceral adipose tissue of the offspring. Although, both DIO and DR offspring had increased 11βHSD1 in the adipose tissue, DR offspring exhibited a healthy metabolic phenotype. Hence, 11βHSD1 could mediate the metabolic effects observed in the prenatally stressed offspring and thus may be a potential mechanism for fetal origins of obesity.